Continuing Medical Education: Primary Care CME: Obesity, Diabetes, and Diet: Combining Evidence for All Three Into Improved Patient Care: CME Outfitters: Online: November 11, 2010 - November 11, 2011
http://www.cmenetworks.com/cme/11676/1/Continuing-Medical-Education-Primary-Care-CME-Obesity-Diabetes-and-Diet-Combining-Evidence-for-All-Three-Into-Improved-Patient-Care-CME-Outfitters-Online-November-11-2010---November-11-2011/Page1.html
CME Outfitters
CME Outfitters is an independent accredited healthcare communications agency providing multidisciplinary continuing medical education content development, production, marketing, accreditation, and project management services to the healthcare industry.
By CME Outfitters
Published on 12/28/2010
Obesity, Diabetes, and Diet: Combining Evidence for All Three Into Improved Patient Care
CME Outfitters, LLC
November 11, 2010 - November 11, 2011
The goal of this activity is to translate evidence-based concepts to real-world applications, and provide clinicians with practical tools, strategies, and resources that can be implemented into clinical practice for the prevention and management of obesity in patients.
CME Sponsor:
CME Outfitters, LLC
Location: Online Activity
Course Directors/Instructors:
Moderator
Louis J. Aronne, MD, FACP
Clinical Professor of Medicine
Weill Cornell Medical College
Adjunct Associate Professor
of Clinical Medicine
Columbia University,
College of Physicians and Surgeons
Director, Comprehensive Weight
Control Program
New York-Presbyterian Hospital/
Weill Cornell Medical Center
New York, NY
Faculty Information
Robert F. Kushner, MD
Clinical Director
Northwestern Comprehensive Center
on Obesity
Professor of Medicine,
Division of General Internal Medicine
Northwestern University Feinberg
School of Medicine
Chicago, IL
Holly Wyatt, MD
Associate Professor of Medicine
Division of Endocrinology, Metabolism
and Diabetes
Center for Human Nutrition
University of Colorado Denver
Denver, CO
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Registration Fee: Free
More Info
Detailed Description:
The National Health and Nutrition Examination Survey (NHANES) data for 2007-2008 reported that the age-adjusted prevalence of obesity among men was 32.2%, and 35.5% among women. Morbidity and mortality related to obesity is well established. Obesity increases the risk of diabetes, cardiovascular disease, some cancers, (colon, endometrial, breast), obstructive sleep apnea/sleep disordered breathing, depression, and stroke. Monitoring weight and health status are central to good clinical practice. Yet surveys indicate that despite recommendations from the 2009 Healthcare Effectiveness Data and Information Set (HEDIS) measures, physicians are not consistently documenting weight, height, blood pressure, and BMI at each visit. Behavior modification and exercise can not only help maintain a healthy weight, but can also prevent or delay the onset of diabetes in patients at risk, but when unsuccessful and a patient’s BMI exceeds 30 kg/m2, experts recommend that physicians consider the addition of pharmacotherapy to the regimen. Researchers are exploring a variety of agents and mechanisms that may be effective in appetite suppression and weight loss. Incretin hormones, which are found in the gastrointestinal system and other tissues, are integral to glucose homeostasis, increasing insulin secretion, reducing glucagon secretion, slowing gastric emptying, and enhancing early satiety. In this webcast, the expert faculty will examine challenges in preventing and managing obesity, and explore emerging strategies to improve patient outcomes.
Learning Objectives:
At the end of this CE activity, participants should be able to:
Intended Audience:
Physicians with an interest in the management of medically obese patients.
Obesity, Diabetes, and Diet: Combining Evidence for All Three Into Improved Patient Care
CME Outfitters, LLC
November 11, 2010 - November 11, 2011
The goal of this activity is to translate evidence-based concepts to real-world applications, and provide clinicians with practical tools, strategies, and resources that can be implemented into clinical practice for the prevention and management of obesity in patients.
Obesity, Diabetes, and Diet: Combining Evidence for All Three Into Improved Patient Care
CME Sponsor:
CME Outfitters, LLC
Location: Online Activity
Course Directors/Instructors:
Moderator
Louis J. Aronne, MD, FACP
Clinical Professor of Medicine
Weill Cornell Medical College
Adjunct Associate Professor
of Clinical Medicine
Columbia University,
College of Physicians and Surgeons
Director, Comprehensive Weight
Control Program
New York-Presbyterian Hospital/
Weill Cornell Medical Center
New York, NY
Faculty Information
Robert F. Kushner, MD
Clinical Director
Northwestern Comprehensive Center
on Obesity
Professor of Medicine,
Division of General Internal Medicine
Northwestern University Feinberg
School of Medicine
Chicago, IL
Holly Wyatt, MD
Associate Professor of Medicine
Division of Endocrinology, Metabolism
and Diabetes
Center for Human Nutrition
University of Colorado Denver
Denver, CO
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Registration Fee: Free
More Info
Detailed Description:
The National Health and Nutrition Examination Survey (NHANES) data for 2007-2008 reported that the age-adjusted prevalence of obesity among men was 32.2%, and 35.5% among women. Morbidity and mortality related to obesity is well established. Obesity increases the risk of diabetes, cardiovascular disease, some cancers, (colon, endometrial, breast), obstructive sleep apnea/sleep disordered breathing, depression, and stroke. Monitoring weight and health status are central to good clinical practice. Yet surveys indicate that despite recommendations from the 2009 Healthcare Effectiveness Data and Information Set (HEDIS) measures, physicians are not consistently documenting weight, height, blood pressure, and BMI at each visit. Behavior modification and exercise can not only help maintain a healthy weight, but can also prevent or delay the onset of diabetes in patients at risk, but when unsuccessful and a patient’s BMI exceeds 30 kg/m2, experts recommend that physicians consider the addition of pharmacotherapy to the regimen. Researchers are exploring a variety of agents and mechanisms that may be effective in appetite suppression and weight loss. Incretin hormones, which are found in the gastrointestinal system and other tissues, are integral to glucose homeostasis, increasing insulin secretion, reducing glucagon secretion, slowing gastric emptying, and enhancing early satiety. In this webcast, the expert faculty will examine challenges in preventing and managing obesity, and explore emerging strategies to improve patient outcomes.
Learning Objectives:
At the end of this CE activity, participants should be able to:
- Integrate quality measures such as regular documentation of BMI, blood pressure, and counseling for nutrition and exercise into the optimal management of patients with obesity.
- Examine the role of incretin hormones in insulin secretion and appetite control.
- Explore the evidence base for current and emerging treatment options for the long-term management of patients with obesity.
Intended Audience:
Physicians with an interest in the management of medically obese patients.